You are here

Article info

Article menu

Download PDFPDF

XML
Review
Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients

Authors

  • Emanuela Romano Department of Medical Oncology, Center for Cancer Immunotherapy, Institut Curie, Paris, Île-de-France, FranceINSERM U932, Department of Immunology, PSL Research University, Institut Curie, Paris, Île-de-France, France PubMed articlesGoogle scholar articles
  • Steve Pascolo Department of Dermatology, University Hospital of Zürich, Zürich, SwitzerlandFaculty of Medicine, University of Zürich, Zürich, Switzerland PubMed articlesGoogle scholar articles
  • Patrick Ott Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USADepartment of Medicine, Brigham and Women’s Hospital, Boston, MA, USAHarvard Medical School, Boston, MA, USABroad Institute of MIT and Harvard, Cambridge, MA, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Emanuela Romano; emanuela.romano{at}curie.fr
View Full Text

Citation

Romano E, Pascolo S, Ott P
Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients
Journal for ImmunoTherapy of Cancer 2021;9:e002932. doi: 10.1136/jitc-2021-002932

Publication history

  • Accepted May 19, 2021
  • First published June 11, 2021.
Online issue publication 
June 11, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.